Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.
To support the deployment of a breakthrough technology, resistance gene enrichment sequencing (RenSeq), to uncover the full repertoire and diversity of immune receptors in three genera of plants, which has the potential to dramatically increase knowledge of how these receptors evolved to mediate microbial interactions and disease resistance.
Thank you for sharing.
Two Blades Foundation (2Blades)
$2,300,000
48 months
Employing a Breakthrough Technology to Uncover the Diversity of Immune Receptors in Plants
Mar 2015
Creating positive outcomes for future generations.
